Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing

Clinical trial NCT05059522 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05059522
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Malignancies NSCLC Ovarian Cancer Urothelial Cancer Solid Tumors

Start date: 2021-09-29
Primary completion: 2026-12-31
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.